SEC Form 4 · accession 0001209191-15-039687
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Cooper
Director
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 9:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1,F2 | $8.13 | May 4, 2015 | A | 13,539 | A | — | Jun 8, 2024 | Common Stock | 13,539 | 13,539 | D |
Explanation of responses
- F1Reporting Person received such stock option in exchange for a stock option to purchase Tobira Therapeutics, Inc. ("Tobira") common stock in connection with the merger of Tobira into Issuer (the "Merger"). Pursuant to the terms of the Merger agreement each Tobira stock option assumed will be determined by multiplying the number of options by the exchange ratio of 1.43 and rounding down to the nearest whole number.
- F225% of the option shares will vest and become exercisable on June 9, 2015, and the remaining shares will vest ratably over the next 36 months of continuous service beginning on July 9, 2015, subject to the terms of the Issuer's 2010 Stock Plan.